Literature DB >> 21492962

Co-colonization with multiple different species of multidrug-resistant gram-negative bacteria.

Graham M Snyder1, Erin O'Fallon, Erika M C D'Agata.   

Abstract

BACKGROUND: The characteristics of co-colonization with multiple different species of multidrug-resistant gram-negative bacteria (MDRGN) have not been fully elucidated. Quantifying the prevalence of co-colonization and those patients at higher risk of co-colonization may have important implications for strategies aimed at limiting the spread of MDRGN.
METHODS: To determine the prevalence of MDRGN colonization, rectal swabs were obtained from 212 residents residing in a 600-bed long-term care facility. Co-colonization was defined as colonization with ≥2 different MDRGN species. Co-colonized residents were compared with residents colonized with a single MDRGN species to identify factors associated with an increased risk for co-colonization. Molecular typing was performed to determine the contribution of cross transmission to the co-colonized state.
RESULTS: A total of 53 (25%) residents was colonized with ≥1 MDRGN. Among these, 11 (21%) were colonized with ≥2 different species of MDRGN. A global deterioration score of ≥5 representing advanced dementia and an increased requirement for assistance from health care workers was significantly associated with co-colonization (P = .05). Clonally related MDRGN strains were identified among 7 (64%) co-colonized residents.
CONCLUSION: The prevalence of co-colonization with ≥2 different MDRGN is substantial. Cross transmission of MDRGN is a major contributor to the co-colonized state.
Copyright © 2011 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21492962      PMCID: PMC3138871          DOI: 10.1016/j.ajic.2010.09.012

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  32 in total

1.  Clinical and economic impact of bacteremia with extended- spectrum-beta-lactamase-producing Enterobacteriaceae.

Authors:  Mitchell J Schwaber; Shiri Navon-Venezia; Keith S Kaye; Ronen Ben-Ami; David Schwartz; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

Review 2.  Antibiotic regimens and intestinal colonization with antibiotic-resistant gram-negative bacilli.

Authors:  Curtis J Donskey
Journal:  Clin Infect Dis       Date:  2006-09-01       Impact factor: 9.079

Review 3.  Management of multidrug-resistant organisms in health care settings, 2006.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

4.  Incidence and prevalence of multidrug-resistant acinetobacter using targeted active surveillance cultures.

Authors:  Lisa L Maragakis; Margaret G Tucker; Redonda G Miller; Karen C Carroll; Trish M Perl
Journal:  JAMA       Date:  2008-06-04       Impact factor: 56.272

5.  The rising influx of multidrug-resistant gram-negative bacilli into a tertiary care hospital.

Authors:  Aurora E Pop-Vicas; Erika M C D'Agata
Journal:  Clin Infect Dis       Date:  2005-05-06       Impact factor: 9.079

6.  How important is patient-to-patient transmission in extended-spectrum beta-lactamase Escherichia coli acquisition.

Authors:  Anthony D Harris; Mamuka Kotetishvili; Simone Shurland; Judy A Johnson; J Glenn Morris; Lucia L Nemoy; J Kristie Johnson
Journal:  Am J Infect Control       Date:  2007-03       Impact factor: 2.918

7.  Impact of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species on clinical outcomes and hospital costs: a matched cohort study.

Authors:  Su Young Lee; Srividya Kotapati; Joseph L Kuti; Charles H Nightingale; David P Nicolau
Journal:  Infect Control Hosp Epidemiol       Date:  2006-10-23       Impact factor: 3.254

8.  Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004.

Authors:  Shawn R Lockhart; Murray A Abramson; Susan E Beekmann; Gale Gallagher; Stefan Riedel; Daniel J Diekema; John P Quinn; Gary V Doern
Journal:  J Clin Microbiol       Date:  2007-08-22       Impact factor: 5.948

9.  Patient-to-patient transmission is important in extended-spectrum beta-lactamase-producing Klebsiella pneumoniae acquisition.

Authors:  A D Harris; E N Perencevich; J K Johnson; D L Paterson; J G Morris; S M Strauss; J A Johnson
Journal:  Clin Infect Dis       Date:  2007-10-16       Impact factor: 9.079

10.  Methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococci co-colonization.

Authors:  Jon P Furuno; Eli N Perencevich; Judith A Johnson; Marc-Oliver Wright; Jessina C McGregor; J Glenn Morris; Sandra M Strauss; Mary-Claire Roghman; Lucia L Nemoy; Harold C Standiford; Joan N Hebden; Anthony D Harris
Journal:  Emerg Infect Dis       Date:  2005-10       Impact factor: 6.883

View more
  10 in total

1.  Network of microbial and antibiotic interactions drive colonization and infection with multidrug-resistant organisms.

Authors:  Joyce Wang; Betsy Foxman; Lona Mody; Evan S Snitkin
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-12       Impact factor: 11.205

2.  Multidrug-Resistant Gram-Negative Bacteria: Inter- and Intradissemination Among Nursing Homes of Residents With Advanced Dementia.

Authors:  Erika M C D'Agata; Daniel Habtemariam; Susan Mitchell
Journal:  Infect Control Hosp Epidemiol       Date:  2015-04-29       Impact factor: 3.254

3.  "Swimming in resistance": Co-colonization with carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii or Pseudomonas aeruginosa.

Authors:  Dror Marchaim; Federico Perez; Jiha Lee; Suchitha Bheemreddy; Andrea M Hujer; Susan Rudin; Kayoko Hayakawa; Paul R Lephart; Christopher Blunden; Maryann Shango; Michelle L Campbell; Jastin Varkey; Palaniappan Manickam; Diixa Patel; Jason M Pogue; Teena Chopra; Emily T Martin; Sorabh Dhar; Robert A Bonomo; Keith S Kaye
Journal:  Am J Infect Control       Date:  2012-02-10       Impact factor: 2.918

4.  Molecular epidemiology of colonizing and disease-causing Klebsiella pneumoniae in paediatric patients.

Authors:  Malaika L Little; Xuan Qin; Danielle M Zerr; Scott J Weissman
Journal:  J Med Microbiol       Date:  2014-01-25       Impact factor: 2.472

5.  Intestinal co-colonization with different carbapenemase-producing Enterobacterales isolates is not a rare event in an OXA-48 endemic area.

Authors:  Marta Hernández-García; Blanca Pérez-Viso; Carolina Navarro-San Francisco; Fernando Baquero; María Isabel Morosini; Patricia Ruiz-Garbajosa; Rafael Cantón
Journal:  EClinicalMedicine       Date:  2019-10-17

6.  Antimicrobial Resistance Gene Prevalence in a Population of Patients with Advanced Dementia Is Related to Specific Pathobionts.

Authors:  Aislinn D Rowan-Nash; Rafael Araos; Erika M C D'Agata; Peter Belenky
Journal:  iScience       Date:  2020-02-13

7.  Epidemiologic and Microbiologic Characteristics of Hospitalized Patients Co-colonized With Multiple Species of Carbapenem-Resistant Enterobacteriaceae in the United States.

Authors:  Timileyin Adediran; Anthony D Harris; J Kristie Johnson; David P Calfee; Loren G Miller; M Hong Nguyen; Daniel J Morgan; Katherine E Goodman; Stephanie Hitchcock; Lisa Pineles; Lyndsay M O'Hara
Journal:  Open Forum Infect Dis       Date:  2020-08-27       Impact factor: 3.835

8.  Unraveling the Diversity of Co-Colonization by CPE.

Authors:  Gabrielle Levi; Mor Lurie-Weinberger; Alona Keren-Paz; Antoine O Andremont; David Schwartz; Yehuda Carmeli
Journal:  Microorganisms       Date:  2022-06-25

9.  Rates of gastrointestinal tract colonization of carbapenem-resistant Enterobacteriaceae and Pseudomonas aeruginosa in hospitals in Saudi Arabia.

Authors:  B Abdalhamid; N Elhadi; N Alabdulqader; K Alsamman; R Aljindan
Journal:  New Microbes New Infect       Date:  2016-01-29

10.  Colonizing multidrug-resistant bacteria and the longitudinal evolution of the intestinal microbiome after liver transplantation.

Authors:  Medini K Annavajhala; Angela Gomez-Simmonds; Nenad Macesic; Sean B Sullivan; Anna Kress; Sabrina D Khan; Marla J Giddins; Stephania Stump; Grace I Kim; Ryan Narain; Elizabeth C Verna; Anne-Catrin Uhlemann
Journal:  Nat Commun       Date:  2019-10-17       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.